These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9671849)

  • 41. The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis.
    Bain SC; Dodson PM
    Postgrad Med J; 1991 Oct; 67(792):922-7. PubMed ID: 1758805
    [No Abstract]   [Full Text] [Related]  

  • 42. Metabolic syndrome: is it a syndrome? Does it matter?
    Kahn R
    Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of hypertension associated with diabetes mellitus].
    Katayama S
    Nihon Rinsho; 1997 Aug; 55(8):2091-6. PubMed ID: 9284429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Introduction: New insight into understanding the relation of type 2 diabetes mellitus, insulin resistance, and cardiovascular disease.
    Hsueh WA
    Am J Cardiol; 2003 Aug; 92(4A):1J-2J. PubMed ID: 12957320
    [No Abstract]   [Full Text] [Related]  

  • 45. Insulin resistance: possible role in the aetiology and clinical course of hypertension.
    Donnelly R; Connell JM
    Clin Sci (Lond); 1992 Sep; 83(3):265-75. PubMed ID: 1327644
    [No Abstract]   [Full Text] [Related]  

  • 46. Hypertension, hyperlipidemia, insulin resistance and obesity: parts of a metabolic syndrome.
    Lind L; Lithell H
    Blood Press Suppl; 1992; 4():49-54. PubMed ID: 1345335
    [No Abstract]   [Full Text] [Related]  

  • 47. [Management of diabetes in cardiac diseases].
    Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin resistance and upper-normal glucose levels in hypertension: a review.
    Cubeddu LX; Hoffmann IS
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S52-5. PubMed ID: 11986895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relation of lipid abnormalities to progression of renal damage in essential hypertension, insulin-dependent and non insulin-dependent diabetes mellitus.
    Walker WG
    Miner Electrolyte Metab; 1993; 19(3):137-43. PubMed ID: 8232100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interactions of hyperlipidemia, hypertension and obesity as coronary risk factors.
    Alexander JK
    Triangle; 1975; 14(1):1-8. PubMed ID: 1099746
    [No Abstract]   [Full Text] [Related]  

  • 51. [How I investigate...the insulin resistance syndrome using biological markers].
    Luyckx F; Scheen AJ; Gielen J; Lefèbvre PJ
    Rev Med Liege; 1997 Oct; 52(10):686-91. PubMed ID: 9446171
    [No Abstract]   [Full Text] [Related]  

  • 52. Metabolic syndrome, diabetes and coronary heart disease.
    Haffner SM
    Int J Clin Pract Suppl; 2002 Oct; (132):31-7. PubMed ID: 12425361
    [No Abstract]   [Full Text] [Related]  

  • 53. Supplement. Obesity, hypertension, insulin resistance and lipid disorders: cross-sectional and longitudinal studies in Japanese adolescents and middle-aged men.
    Hirose H; Saito I; Saruta T
    Intern Med; 1999 Feb; 38(2):198-200. PubMed ID: 10225686
    [No Abstract]   [Full Text] [Related]  

  • 54. Management of diabetes mellitus and insulin resistance in patients with cardiovascular disease.
    Fonseca VA
    Am J Cardiol; 2003 Aug; 92(4A):50J-60J. PubMed ID: 12957327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Reaven's metabolic syndrome X in the families of individuals with premature cerebrovascular attacks].
    Vaverková H; Ficker L; Vlachová I; Chudácková J; Novotný D; Budíková M
    Vnitr Lek; 1993 Aug; 39(8):745-54. PubMed ID: 8212622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Coronary risk factors. Anatomoclinical study].
    Degeratu T; Nicolaescu V; Nuţă M; Cîmpeanu A; Cucu N
    Med Interna (Bucur); 1974 Jan; 26(1):61-72. PubMed ID: 4821152
    [No Abstract]   [Full Text] [Related]  

  • 57. Non-alcoholic fatty liver: a common manifestation of a metabolic disorder.
    Malnick SD; Beergabel M; Knobler H
    QJM; 2003 Oct; 96(10):699-709. PubMed ID: 14500857
    [No Abstract]   [Full Text] [Related]  

  • 58. [Sibutramine in treatment of obesity. Therapeutic premises in patients with essential hypertension, diabetes, hyperlipidemia].
    Rajzer M; Wojciechowska W; Kawecka-Jaszcz K
    Przegl Lek; 2004; 61(2):94-8. PubMed ID: 15230149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease.
    Reaven GM
    Am Heart J; 1991 Apr; 121(4 Pt 2):1283-8. PubMed ID: 2008857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cerebral perfusion in patients with metabolic syndrome].
    Chazova IE; Mychka VB; Gornostaev VV; Dvoskina IM; Sergienko VB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; (Suppl 13):8-13. PubMed ID: 15986820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.